Therefore, we performed an updated meta-analysis to aim to come up with the highest level of evidence for the associations between three SNPs in TOX3 gene and breast cancer risk among diverse ancestry populations and distinct tumor subtypes stratified by estrogen receptor (ER) or BRCA1/BRCA2. This evidence concerns the gene BRCA2 and breast carcinoma.